Category Archives: Coronary Heart Diseases

Marginalizing womens vascular health has clinical and economic consequences that conflict with the goal of improving population health. In Puerto Rico, heart disease is the leading cause of death in the population. Photo: Shutterstock. Continue reading →

Get to know Interventional Cardiologist Dr. Continue reading →

Men of European descent over the age of 50 are the most vulnerable for the development of atherosclerosis the most common disorder associated with cardiovascular diseases (CVDs). According to a new study by researchers in the Human Molecular Biology Unit in the School of Biomedical Sciences at the University of the Free State (UFS) into atherosclerosis in South Africa, nearly half of men in this group had visible signs of atherosclerosis in the coronary arteries of the heart. Continue reading →

Colchicine is an inexpensive new treatment for coronary heart disease that is both safe and effective in select patients Cardiovascular disease imposes a major burden on Australians and the Australian health care system. Due to campaigns to reduce smoking and the widespread use of effective lipidlowering therapy, there has been a significant decline in the death rate from cardiovascular disease over several decades.1 However, nearly 600000 patients are hospitalised each year with cardiovascular disease, at a cost to the community of over $4 billion in 201819.1 Patients with coronary heart disease face an ongoing risk of cardiovascular events even when their lipidlowering and antithrombotic therapy is optimal. Thus, to reduce morbidity in these patients, there is a need for doctors to employ additional therapies that are effective, safe, readily available and costefficient for this purpose Continue reading →

Deepak Bhatt, MD, MPH: Were going to move on to not just identifying polyvascular disease, but what to do about it. Ill start with you, Amy. What do the guidelines from the ACC [American College of Cardiology] and the AHA [American Heart Association] tell us about managing coronary artery disease [CAD] Continue reading →

Latest Study on Industrial Growth of Global Cardiac Medication Market 2021-2027. A detailed study accumulated to offer Latest insights about acute features of the Cardiac Medication market Continue reading →

This article was originally published here Braz J Cardiovasc Surg. 2022 May 2;37(2):219-226. Continue reading →

The global Diagnostic Electrocardiograph market is expected to grow from $ billion in 2020 to $ billion in 2028 at a CAGR of XX%. A diagnostic electrocardiograph is a medical device that enables the diagnosis of the hearts electrical function-associated issues. The electrodes identify the tiny electrical modifications that occur on the skin from the depolarization of the heart muscle during each heartbeat. Continue reading →

The global interventional cardiology and peripheral vascular devices market size was US$ 19415.62 million in 2021. Continue reading →

The global cardiovascular diagnostic testing market revenue was US$ 6,876.27 million in 2020. The global cardiovascular diagnostic testing market revenue is forecast to reach US$ 15,430.44 million by 2030, growing at a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2021-2030. Cardiovascular Diagnostic Testing MarketStatus, Trends and COVID-19 Impact Report 2021, Covid 19 Outbreak Impact research report added by Report Ocean, is an in-depth analysis of market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies for this market. Continue reading →